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Summary 
Virus infections of the lung are thought to predispose individuals to asthma, a disease characterized 
by eosinophil infiltration of the airways. CD8 + T cells are an important part of the host response 
to virus infection, however, they have no reported role in eosinophil recruitment.  We developed 
a mouse model of virus peptide-stimulated  CD8 + T  cell immune responses in the lung.  We 
found that bystander CD4 + T  helper cell type 2 immune responses to ovalbumin switched the 
virus peptide-specific CD8 + T  cells in the lung to interleukin (IL) 5 production. Furthermore, 
when such IL-5-producing CD8 T  cells were challenged via the airways with virus peptide, 
a significant eosinophil infiltration was induced. In vitro studies indicated that IL-4 could switch 
the virus-specific  CD8 + T cells to IL-5 production. These results could explain  the link between 
virus infection and acute exacerbation of asthma and, perhaps more importantly,  they indicate 
an  IL-4-dependent  mechanism  that  would  impair  CD8 +  T  cell  responses  and  delay  viral 
clearance from the host. 
I 
nfiltration  and activation of eosinophils in the bronchial 
mucosa is believed to be a central event in the pathogen- 
esis of asthma (1). The major stimulus for eosinophil accumu- 
lation is thought to be allergen-stimulated production of IL-5 
by CD4 + TH2 cells (2, 3). However, virus infection of the 
upper respiratory tract is also thought to predispose towards 
and exacerbate bronchial asthma (4, 5). The precise mecha- 
nism(s) by which virus infection brings this about has not 
yet been defined. 
Virus infection of the host leads to the activation of both 
CD4 + and CD8 + T cell-mediated immune responses. CD8 + 
T  cells help control virus replication by the production  of 
IFN-3'  and  lysis  of virus-infected  cells  (6).  In  fact,  some 
workers have suggested that the IFN-3' produced by CD8 + 
T  cells  can suppress CD4 + TH2 responses in  the airways 
(7, 8). 
Recently, it has been demonstrated that CD8 + T cells ac- 
tivated in the presence of IL-4 can switch to a noncytolytic 
phenotype that produces the TH2 cytokines IL-4, IL-5, and 
IL-IO and provides help for B cells (9). This observation sug- 
gested the possibility that virus-specific CD8 + T  cells have 
the potential  to develop into IL-5-producing  cells and be- 
come a major stimulus for eosinophil recruitment  into the 
lung. In the present study, we have investigated whether in- 
duction of a local TH2 immune response could modify the 
pattern of cytokines produced by CD8 + T  cells and deter- 
mine whether  this change in functional phenotype would 
have pathophysiological  consequences. 
Materials and Methods 
Mice 
To study virus peptide-specific CD8 + T cell immune responses 
we made use of transgenic mice expressing an H-2Db-restricted 
TCR specific for the glycoprotein epitope 33-41 of the lympho- 
cytic choriomeningitis  virus (LCMV) 1 (10). The TCR transgenic 
mouse line 318 used in this study is able to respond normally to 
antigens unrelated to I.CMV because the transgenic TCR is ex- 
pressed only on 50-60% of CD8 + T cells, and normal numbers 
of CD4 + T cells with endogenous  TCR are found in the lym- 
phoid organs (11). For the in vitro studies, we made use of a second 
transgenic mouse line (No. 327) which expresses the LCMV-specific 
TCR on 100% of the CD8 + T cells (11). 
Immunization 
A TH2 immune response was induced by immunizing  8-wk- 
old C57BL/6 or LCMV TCR transgenic mice intraperitoneally 
on days 0 and 14 with 2 #g of OVA (Sigma Chemical Co.,  St. 
Louis, MO) in 4 mg of alum adjuvant (SERVA, Heidelberg, Ger- 
many). Sham-immunized mice received two injections of alum alone. 
Virus Peptide-induced Airumy Inflammation 
LCMV-specific TCR transgenic mice or nontransgenic C57BL/6 
mice were either sham immunized or sensitized to OVA as described 
1  Abbreviations used in this paper: BAL,  bronchoalveolar lavage; LCMV, 
lymphocytic choriomeningitis virus. 
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norm (Janssen, Baar, Switzerland) and Dormicom (Roche, Basel, 
Switzerland), and 50/~1 of LCMV glycoprotein 33-41 peptide (9) 
(2 mg/ml) was administered to the airways via the intranasal route, 
the animals were then allowed to recover. 72 h later, animals were 
anesthetised with urethane (14% wt/vol), the trachea cannulated, 
and a bronchoalveolar lavage (BAL) performed by five repeated 
lavages with 0.3 ml of saline. Cytospin preparations were prepared 
and the cellular composition  of the BAL fluid quantified  after 
staining with Dif-Quik (Dade Baxter, Miami, FL) using standard 
histological criteria. 
Purification of Lung  T  Cells 
To prepare T cells from the lung, BAL was performed five times 
with 1 ml of sterile PBS to remove resident pulmonary macrophages. 
The thorax was then opened and the lungs perfused via the right 
ventricle with 10 ml of PBS containing  500 U/ml of heparin to 
remove contaminating blood. Lungs were removed, homogenized, 
and the resulting cell suspension faltered through a 70-1xm filter, 
and lymphocytes enriched over a single-step Ficoll gradient.  The 
cells were then labeled with Thyl.2-PE (PharMingen,  San Diego, 
CA) and sorted by flow cytometry. 
Cytokine  Production by Lung  T  Cells 
Anti-CD3-induced Cytokine Production.  FACS  |  (Becton Dick- 
inson & Co., Mountain View, CA) sorted lung T cells (>99.5% 
pure) were cultured  (2  x  105 cells/well) on an anti-CD3-coated 
(2Cll, 50 #g/ml) 96-well plate (Nunc, Roskilde, Denmark) in the 
presence of hlL-2 (200 U/ml) for 72 h.  Supematants  were then 
harvested and the production  of cytokines (II.-2, I/--4, IL-5, and 
IFN-y) determined by ELISA (PharMingen) as described previously 
(12). The limits of cytokine detection were 0.2 U/ml (Ib2), 20 
U/ml (Ib4),  150 U/ml (II.,5), and 20 U/ml (IFN-~/) (12). 
LCMV  Peptide-induced Cytokine Production.  FACS  |  sorted 
Thyl.2 + cells (>99.5% pure) derived from LCMV-specific TCR 
transgenic mice were cultured in 96-well plates (2  x  10S/well)  and 
stimulated with  10/~g/ml of LCMV peptide  and l0  s irradiated 
EL-4 target cells/well in the presence of hlL-2 (200 U/ml) for 72 h. 
Supernatants were harvested and Ib5 and IFN-3r levels measured 
by ELISA (PharMingen). 
LCMV Peptide-specific In  Vitro Immune Response Assay 
CD8 + T  cells were prepared from the LCMV-specific TCR 
transgenic mouse line 327, by removal of CD4 + T  and B cells 
with specific antibodies (GK1.5 and sheep anti-mouse Ig) (12) and 
magnetic beads (Dynabeads; Dynal, Oslo, Norway). The remaining 
cell population  was then labeled with CD8-FITC (PharMingen) 
and small CD8 § T cells were purified (>99.5%  purity) by flow 
cytometry. CD8 + T cells were cultured (800 cells per well) in 96 
U-bottom well plates (Nunc) for 6 d in the presence of the viral 
peptide (11) (1/zg/ml) and Ib2 (200 U/m1) with or without IL-4 
(500 U/ml). Cells were harvested from each culture, washed, and 
recultured  (105 ceils per well) on an  anti-CD3-coated  plate (50 
/zg/ml) in the presence ofhlL2 (200 U/ml) for 48 h. The superna- 
tants were assayed for the cytokines IL-5 and IFN-~/by ELISA. 
Greater than 99% of cells at the end of the 6-d culture period were 
surface positive for the transgenic Vcr  and VB8.1 chains (Phar- 
Mingen antibodies B20.1 and MR5-2, respectively) indicating that 
only the LCMV-specific cells were activated. 
Results 
Induction of a TH2-immune Response in the Lungs of OVA- 
immunized Mice.  Thy-l.2 + T  ceils were purified from the 
lungs of OVA- and sham-immunized mice, and their poten- 
tial for cytokine production determined by stimulation with 
plate-bound anti-CD3 antibodies. Lung T cells from sham- 
immunized  mice produced IL-2 and IFN-% with no IL-4 
or IL-5 being detected.  By contrast,  T  cells isolated from 
the lungs of OVA-immunized mice produced significant  levels 
of IL-4 and IL-5, but very little IFN-~/or IL-2, indicating 
that they were "TH2 like" (Fig. 1). Spleen- or lymph node--de- 
rived T  cells  from both OVA- and sham-immunized  mice 
produced IL-2 and IFN-3' (data not shown) and no detect- 
able IL-4 and IL-5 when stimulated with anti-CD3 antibodies. 
This would indicate that  there was a selective enrichment 
of OVA-primed TH2 cells in the lung tissues. Serum analysis 
of OVA-immunized mice indicated that detectable levels of 
IgE were induced (data not shown). These IgE levels were 
maintained for many months,  indicating that  IL-4 produc- 
tion was ongoing in these immunized  mice. 
Effect  of  TH2  Immunization  on  Lung  CD8 ~  T  Cell 
Cytokine Production.  The OVA/alum immunization protocol 
was applied to the LMCV-specific TCR transgenic mice. The 
purpose of the experiment was to determine whether the OVA- 
induced TH2 response in the lung could switch naive LCMV- 
specific  CD8 +  T  cells  to  IL-5  production.  T  ceils  were 
purified from the lungs of OVA-immunized LCMV-specific 
TCR transgenic mice. In vitro stimulation of the lung T cells 
from sham-immunized mice with the I.CMV peptide resulted 
in IFN-~/production and no detectable IL-5 (Fig. 2). By con- 
trast, lung T cells from the OVA-immunized mice produced 
IL-5 and reduced amounts of IFN-qr (Fig.  2). Importantly, 
T ceils from lymph nodes or spleens of OVA-immunized mice 
did not produce detectable IL-5 upon viral peptide stimula- 
tion in vitro (data not shown), indicating that only the LCMV 
peptide-specific  CD8*  T  cells  in  the  lung  had  switched 
phenotype.  No cytokines were detected in cultures stimu- 
lated with EL-4 target cells alone or cultures of target cells 
plus  the viral peptide. 
Effect of TH2 Immunization  on a CD8 + T Cell-induced In- 
flammatory Response in the Lung.  It was important to deter- 
mine whether the switch of LCMV peptide-specific CD8 + 
T cells to IL-5 production would lead to eosinophil recruit- 
ment if the lungs were subsequently exposed to LCMV pep- 
tide. Transgenic  mice previously immunized against OVA de- 
veloped a BAL eosinophilia when intranasally  inoculated with 
the LCMV peptide (Fig. 3 A). However, LCMV peptide chal- 
lenge  of the  sham-immunized  transgenic  mice led to  the 
recruitment  of some neutrophils  and lymphocytes but no 
eosinophils  (Fig.  3  A).  Nontransgenic,  OVA-immunized 
C57BL/6 mice did not develop any inflammatory cell infiltrate 
upon viral peptide challenge, indicating that the eosinophil 
infiltration  was dependent  on  the  LCMV peptide-specific 
CD8 § T cells,  and was not due to recognition of the virus 
peptide by OVA-specific  CD4 + T  cells  (Fig.  3 B). 
These results support the notion that a TH2 immune re- 
sponse to unrelated antigens can modify the functional poten- 
tial  of bystander  naive  CD8 +  T  cells  to  the  degree,  that 
when they meet their  specific antigen  in the form of class 
I MHC-associated virus peptide, they can produce IL-5 and 
recruit  eosinophils into  the lung. 
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Figure  1.  Cytokine production profile of anti-CD3-stimu- 
lated, purified lung T cells from sham- or OVA-immunized 
C57BL/6 mice. Data are shown as the mean +  SEM of three 
separate cultures  with n  =  5 mice in each group. 
Role of IL-4 in the In  Vitro Switch of Viral-specific CD8* 
Cells to IL-5 Production.  We questioned how a TH2 immune 
response could influence the phenotype of bystander virus- 
specific CD8 + T  cells.  To study this we established an in 
vitro immune response model using FACS|  LCMV 
peptide-specific CD8 + T ceils from transgenic mice. By ac- 
tivating the T ceils with LCMV peptide in the presence of 
various costimulatory factors we hoped to identify which 
cytokine might be relevant to the in vivo switch of CD8 ceils 
to IL-5 production. CD8 + T cells activated in the presence 
of IL-2 became well activated, proliferated, and produced 
IFN-'y when restimulated with plate-bound anti-CD3 anti- 
body (Fig.  4). However, if IL-4 was also added to the pri- 
mary cultures, the resulting CD8 T ceUs produced IL-5 and 
reduced amounts of IFN-3~ when restimulated with anti-CD3 
antibody (Fig. 4). The surface phenotype of the 6-d cultured 
CD8 T cells, both in the presence and absence of IL-4, was 
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Figure  2.  Cytokine production profile of LCMV peptide-stimulated, 
purified lung T cells from sham- or OVA-immunized, I.CMV-specific  TCR 
transgenic mice. Each column represents cytokine production (Units/ml) 
from T cells derived from the lungs of five mice and was reproduced  in 
two separate experiments. 
99%  positive for the expression of the TCR ot (Vot2)  and 
B (VBS.1) chain transgenes, indicating that all the in vitro- 
activated CD8  T  cells were LCMV peptide  specific  (data 
not shown). 
Discussion 
Infiltration and activation of eosinophils in the bronchial 
mucosa is believed to be a central event in the pathogenesis 
of asthma (13). There is now strong epidemiological and clin- 
ical evidence to suggest that viral infections can exacerbate 
the symptoms of asthma (14).  Paradoxically,  a major host 
response against virus  infection is  the activation of IFN- 
y-producing  CD8  T  cells,  which are thought  to be  an- 
tagonistic to eosinophil activity and are proposed to suppress 
TH2 immune responses in the lung (7). Therefore, the link 
between viral infection, CD8 § T cell activation, and eosin- 
ophil accumulation in asthmatics remains unexplained. 
In our mouse model of LCMV-specific CD8 + T  cell re- 
sponses we found that the induction of a TH2 immune re- 
sponse to OVA switched the subsequent bystander LCMV- 
specific CD8 + T  cell response to IL-5 production, leading 
to the accumulation of eosinophils in the lung. By contrast, 
the LCMV peptide-specific,  CD8 T  cell-induced response 
in non- or sham-immunized transgenic mice resulted in an 
accumulation of neutrophils, without any detectable eosino- 
phil recruitment. It was clear that the virus peptide-induced 
inflammatory response in both the sham- and OVA-immunized 
transgenic mice was due to CD8 + T  cells specific for the 
LCMV peptide, as peptide provocation of nontransgenic mice 
failed to induce any inflammatory changes in the lung. 
In vitro analysis of the cytokines produced by the LCMV 
peptide-specific lung CD8 + T  cells revealed the cells from 
OVA-immunized mice produced IL-5 and reduced levels of 
IFN-?, whereas CD8 + T cells from sham-immunized mice 
secreted large amounts of IFN-y and no detectable IL-5. To 
our knowledge, this is the first in vivo demonstration that 
CD8 + T cells can switch functional phenotype and become 
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Figure  3.  Inflammatory cell composition of BAL fluid taken from ei- 
ther sham- or OVA-immunized mice 72  h  after LCMV peptide aerosol 
challenge. (A) OVA- and sham-immunized LCMV-specific TCR transgenic 
mice or (B) OVA-immunized  nontransgenic C57BL/6 mice. Cell number 
is shown as the mean _+ SEM ofn =  6-8 animals and expressed as cells/ml 
x  10  3. 
associated with a pathophysiological  outcome,  i.e., eosino- 
phil accumulation. 
The detection of significant levels of IgE in the serum of 
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Figure  4.  Cytokine production by LCMV-specific CD8 T cells activated 
in the presence or absence of IL-4. FACS|  I.CMV peptide-specific 
CD8 + T cells were stimulated with the LCMV peptide in cultures con- 
taining IL-2 in the absence or presence of I/-,4 (500 U/ml). Cultured cells 
were washed and restimulated with plate-bound anti-CD3 antibodies and 
cytokine production was measured in the supernatants after 48 h. Data 
are presented as the mean  -+ SEM of three separate cultures and cytokine 
production  expressed as units/ml. 
OVA-immunized  mice indicated that IL-4 production  was 
induced by the immunization  (data not shown) which could 
possibly influence the CD8 + T cells. Our in vitro  experi- 
ments demonstrated that IL-4 combined with viral peptide 
stimulation  could  switch  the cytokine  profile of CD8 § T 
cells from IFN-3' production  to IL-5 production.  Such an 
IL-4-dependent switch to a TH2 phenotype has already been 
reported to operate with naive CD4 + T  cells (15). 
In asthmatic individuals, the local TH2 environment exists 
in the lung which could switch any virus-specific CD8 + T 
cell response to IL-5 production  (3).  Not only would the 
impaired secretion of IFN-7 result in delayed clearance of the 
virus from the respiratory tract, but virus-induced produc- 
tion of IL-5 by lung CD8 + T  cells would exacerbate the 
symptoms of asthma by inducing eosinophil infiltration into 
the airways (16, 17). Subsequent eosinophil  activation and 
release of eosinophil-derived cationic proteins, such as major 
basic protein would result in a cascade of events leading to 
the development of airway hyperresponsiveness, a character- 
istic feature of bronchial asthma (18). 
The implications of these results may not be confined to 
viral infections in asthmatics. In any infectious disease situa- 
tion where a cytolytic,  IFN-7-producing CD8 + T cell re- 
sponse is required for protection,  the switch  of the CD8 ~ 
T cells to a TH2 phenotype could leave the host immunocom- 
promised. 
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